跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Butaciram - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Butaciram
Approved
STANDARD
Butaciram
Orion Pharma Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
8a2edeebfc06e238
Company
Orion Pharma Ltd
Type
Standard
Approval Details
Approval Id
8a2edeebfc06e238
Drug Approval Philippines Name
Butaciram
Product Name
Butaciram
Registration Number
DRP-11108-02
Brand Name
Butaciram
Generic Name
Butamirate Citrate
Dosage Form
Film-Coated Sustained-Release Tablet
Dosage Strength
50 mg
Manufacturer
Orion Pharma Ltd
Importer
Ambica International Corporation
Distributor
AGB Pharmaceutical Trading and Consultancy Corporation
Issuance Date
27 May 2022
Expiry Date
03 February 2027
Pharmacologic Category
Antitussive
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
8a2edeebfc06e238
Type
Standard
Back to Philippines FDA Approvals